Search research articles
Contact Us
Filters
Showing results (61-70 of 157) with videos related to
Page
of 16
Sort By:
Frontiers in Pharmacology
|
October 30, 2016
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
Cristian Lolli, Orazio Caffo, Emanuela Scarpi, et al.
The Prostate
|
May 19, 2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
Vincenza Conteduca, Orazio Caffo, Lisa Derosa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 27, 2015
(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Ugo De Giorgi, Paola Caroli, Emanuela Scarpi, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer
Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, et al.
Molecular Oncology
|
October 17, 2021
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome
Vincenza Conteduca, Emanuela Scarpi, Paola Caroli, et al.
International Journal of Molecular Sciences
|
December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are Headed
Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Oncotarget
|
May 19, 2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, et al.
Cancers
|
March 6, 2021
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
Giuseppe Schepisi, Caterina Gianni, Sara Bleve, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 157) with videos related to
Sort By:
Page
of 16
Frontiers in Pharmacology
|
October 30, 2016
Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone
Cristian Lolli, Orazio Caffo, Emanuela Scarpi, et al.
The Prostate
|
May 19, 2015
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone
Vincenza Conteduca, Orazio Caffo, Lisa Derosa, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 27, 2015
(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide
Ugo De Giorgi, Paola Caroli, Emanuela Scarpi, et al.
Pharmaceuticals (Basel, Switzerland)
|
November 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer
Vicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín, et al.
International Journal of Molecular Sciences
|
July 27, 2022
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation
Francesca Sanguedolce, Magda Zanelli, Andrea Palicelli, et al.
Molecular Oncology
|
October 17, 2021
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome
Vincenza Conteduca, Emanuela Scarpi, Paola Caroli, et al.
International Journal of Molecular Sciences
|
December 6, 2017
Immunotherapy for Prostate Cancer: Where We Are Headed
Giuseppe Schepisi, Alberto Farolfi, Vincenza Conteduca, et al.
Oncotarget
|
May 19, 2016
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer
Samanta Salvi, Valentina Casadio, Vincenza Conteduca, et al.
Cancers
|
March 6, 2021
Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy
Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, et al.
International Journal of Molecular Sciences
|
June 2, 2021
Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
Giuseppe Schepisi, Caterina Gianni, Sara Bleve, et al.
Page
of 16